(Q43567352)

24 November 2017

title

Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas (English)

1 reference

24 November 2017

0 references

1 reference

1 reference

L A Kachnic

1

1 reference

24 November 2017

J E Shaw

2

1 reference

24 November 2017

M A Manning

3

1 reference

24 November 2017

A D Lauve

4

1 reference

24 November 2017

J P Neifeld

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

International Journal of Cancer

24 November 2017

published in

1 reference

24 November 2017

volume

96

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

132-139

1 reference

24 November 2017

cites work

Cancer statistics, 1999.

1 reference

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

21 January 2018

1 reference

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

21 January 2018

1 reference

Survival in 1001 patients with carcinoma of the pancreas

21 January 2018

1 reference

Surgical palliation for pancreatic cancer. The UCLA experience

21 January 2018

1 reference

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

21 January 2018

1 reference

Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapy

21 January 2018

1 reference

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

21 January 2018

1 reference

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

21 January 2018

1 reference

Phase II study of gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma

21 January 2018

1 reference

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy

21 January 2018

1 reference

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience

21 January 2018

1 reference

Periampullary adenocarcinoma: analysis of 5-year survivors

21 January 2018

1 reference

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

21 January 2018

1 reference

Adjuvant therapy for pancreatic cancer

21 January 2018

1 reference

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

21 January 2018

1 reference

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

21 January 2018

1 reference

Patterns of failure after curative resection of pancreatic carcinoma

21 January 2018

1 reference

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

21 January 2018

1 reference

Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Radiation Therapy Oncology Group

21 January 2018

1 reference

Response of pancreatic cancer to local irradiation with high-energy neutrons

21 January 2018

1 reference

Adjuvant therapy of resected adenocarcinoma of the pancreas

21 January 2018

1 reference

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

21 January 2018

1 reference

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma

21 January 2018

1 reference

Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma

21 January 2018

1 reference

Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma

21 January 2018

1 reference

Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1008

1 reference

24 November 2017

1 reference